Stay updated with breaking news from Randomized Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research reports the results of a phase 3 clinical trial evaluating the safety, immunogenicity, and efficacy of the NVX-CoV2373 vaccine in adolescents aged 12 to 17 years. The study found that the vaccine was safe, immunogenic, and efficacious in preventing COVID-19, including the Delta variant, in adolescents.
Find out all about the Relief Factor supplement, how it works for joint paint and other alternatives in 2023. Read our Relief Factor reviews.
New research showed mixed results with perturbation-based balance training, or PBT, for older adults living in communities and their rate of falls.
A look at the arguments for and against the use of medicinal cannabis
Scores for the 20-Item Symptom Checklist improved from baseline over gestation in the interpersonal psychotherapy cohort, but not in the enhanced usual care group.